Thursday, November 17, 2011
Print Current Session:
|
|
Thursday
SESSION 13:
HEPATOCELLULAR CARCINOMA
Moderators:Curtis W. Bakal, MD, MPH / George I. Getrajdman, MD
|
|
SESSION 13 SCHEDULE | |
2:50 PM - 3:00 PM | Assessment, Staging And Triage Of Patients With HCC |
Presenter(s):Daniel Y. Sze, MD, PhD | |
3:00 PM - 3:10 PM | Debate: Conventional TACE: How To Do It And Why It Is Best |
Presenter(s):Michael C. Soulen, MD | |
3:10 PM - 3:20 PM | Debate: TACE Using DEB Is Best: How I Do It And The Value Of Periprocedure Anti-Angiogenesis Therapy |
Presenter(s):Jean Francois H. Geschwind, MD | |
3:30 PM - 3:40 PM | Debate: y-90 Is The Best Treatment For HCC |
Presenter(s):Riad Salem, MD, MBA | |
3:40 PM - 3:50 PM | Immediate CT Post DEB TACE Helps Predict Adequacy Of TACE |
Presenter(s):Jacob Cynamon, MD | |
3:50 PM - 4:00 PM | Finding The Obscure Vessel Feeding The Tumor |
Presenter(s):Jonathan Susman, MD | |
4:00 PM - 4:10 PM | Indications, Technique And Assessment Of PV Embolization |
Presenter(s):David C. Madoff, MD | |
4:10 PM - 4:20 PM | Overview Of The Various Ablation Devices |
Presenter(s):Riccardo Lencioni, MD | |
4:20 PM - 4:30 PM | Biopsy After Ablation: What To Look For And Why It Should Be Standard Of Care |
Presenter(s):Constantinos T. Sofocleous, MD, PhD | |
4:30 PM - 4:40 PM | HIFU For HCC |
Presenter(s):Franco Orsi, MD | |
4:40 PM - 4:50 PM | When Is Radiation Indicated And Are Fiducials Necessary? |
Presenter(s):Nishita Kothary, MD | |
4:50 PM - 5:00 PM | Panel Discussion |
END OF SESSION 13 | |
previous | next |